Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -5.33 % |
3 Month Return | -2.45 % |
1 Year Return | -9.38 % |
Market Stats | |
Previous Close | ₹58.94 |
Open | ₹58.18 |
Volume | 8,435.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹56.94Cr |
P/E Ratio | 37.54 |
PEG Ratio | 750.83 |
Market Cap | ₹56.94 Cr |
P/B Ratio | 1.37 |
EPS | 1.51 |
Dividend Yield | 1.39 |
Sector | Pharmaceuticals |
ROE | 3.66 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹56.94 Cr | 58.33% | 0.50 | ₹1 Cr | ₹67 Cr | |
NA | ₹207.23 Cr | 49.33% | 0.79 | ₹7 Cr | ₹339 Cr | |
NA | ₹10.56 Cr | 219.49% | 0.50 | NA | NA | |
BUY | ₹6,511.04 Cr | 14.02% | 0.62 | ₹48 Cr | ₹717 Cr | |
NA | ₹28.64 Cr | 67.38% | 0.50 | NA | NA |
Organisation | Sandu Pharmaceuticals Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 15.91 Cr → 17.09 Cr (in ₹), with an average increase of 6.9% per quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 57.09% of holdings in Sep 2024 quarter
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 83.8% return, outperforming this stock by 93.1%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 133.4% return, outperforming this stock by 116.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 42.90% of holdings in Sep 2024 quarter
Profit Down
Netprofit is down for the last 2 quarters, 0.59 Cr → 0.17 Cr (in ₹), with an average decrease of 71.2% per quarter
Price Dip
In the last 1 year, Sandu Pharma. stock has moved down by -9.4%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 42.9% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 57.09% | 0.00 | |
Others | 0.01% | 0.00 |
Sandu Pharmaceuticals Ltd in the last 5 years
Lowest (30.50x)
June 20, 2022
Today (37.54x)
October 18, 2024
Industry (58.10x)
October 18, 2024
Highest (66.08x)
February 19, 2024
Sandu Pharmaceuticals Ltd’s net profit jumped 54.55% since last year same period to ₹0.17Cr in the Q1 2024-2025. On a quarterly growth basis, Sandu Pharmaceuticals Ltd has generated -71.19% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2024, Sandu Pharmaceuticals Ltd has declared dividend of ₹0.80 - translating a dividend yield of 2.79%.
Read More about DividendsBearish
Neutral
Bullish
Sandu Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Sandu Pharmaceuticals Ltd (524703) share price today is ₹55.5
Sandu Pharmaceuticals Ltd is not listed on NSE
Sandu Pharmaceuticals Ltd is listed on BSE
PE Ratio of Sandu Pharmaceuticals Ltd is 37.54
PE ratio = Sandu Pharmaceuticals Ltd Market price per share / Sandu Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Sandu Pharmaceuticals Ltd(524703) is 8,435.00.
Today’s market capitalisation of Sandu Pharmaceuticals Ltd(524703) is ₹56.94Cr.
Sandu Pharmaceuticals Ltd(524703 | Price |
---|---|
52 Week High | ₹85 |
52 Week Low | ₹55.15 |
Sandu Pharmaceuticals Ltd(524703) share price is ₹55.5. It is down -34.71% from its 52 Week High price of ₹85
Sandu Pharmaceuticals Ltd(524703) share price is ₹55.5. It is up 0.63% from its 52 Week Low price of ₹55.15
Sandu Pharmaceuticals Ltd(524703 | Returns |
---|---|
1 Day Returns | -3.44% |
1 Month Returns | -5.33% |
3 Month Returns | -2.45% |
1 Year Returns | -9.38% |